Paper25795124
Crosstalk between translesion synthesis, Fanconi anemia network, and homologous recombination repair pathways in interstrand DNA crosslink repair and development of chemoresistance.
Haynes B and 3 others. Mutat Res Rev Mutat Res, 2015. Cited by 62 papers, by iCite.
Cite this record
ConductScience Library. Crosstalk between translesion synthesis, Fanconi anemia network, and homologous recombination repair pathways in interstrand DNA crosslink repair and development of chemoresistance. Papers, record 25795124. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25795124
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Crosstalk between translesion synthesis, Fanconi anemia network, and homologous recombination repair pathways in interstrand DNA crosslink repair and development of chemoresistance.
- PubMed
- Publication types
- Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., Review
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| DNA | Major topic |
| DNA Repair | Major topic |
| DNA-Directed DNA Polymerase | Major topic |
| Fanconi Anemia Complementation Group Proteins | Major topic |
| Neoplasms | Major topic |
| Antineoplastic Agents | |
| DNA Damage | |
| Drug Resistance, Neoplasm | |
| Humans | |
| Mutagens | |
| Recombinational DNA Repair | |
| Signal Transduction |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| R21 CA178117 | NCI NIH HHS | United States | R21CA178117 | PubMed and NIH | NIH RePORTER |
| R25 GM058905 | NIGMS NIH HHS | United States | R25GM058905 | PubMed and NIH | NIH RePORTER |
| T32 CA009531 | NCI NIH HHS | United States | T32CA009531 | PubMed and NIH | NIH RePORTER |
| CA178117 | NCI NIH HHS | United States | R21CA178117 | PubMed and NIH | NIH RePORTER |
References102
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 20400964 | Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene. | Nat Genet | 2010 | https://conductscience.org/library/papers/20400964 | PubMed |
| 2 | 19466589 | Utility of DNA postreplication repair protein Rad6B in neoadjuvant chemotherapy response. | Med Oncol | 2010 | https://conductscience.org/library/papers/19466589 | PubMed |
| 3 | 20534341 | DNA topoisomerases and their poisoning by anticancer and antibacterial drugs. | Chem Biol | 2010 | https://conductscience.org/library/papers/20534341 | PubMed |
| 4 | 20670894 | The FANCM/FAAP24 complex is required for the DNA interstrand crosslink-induced checkpoint response. | Mol Cell | 2010 | https://conductscience.org/library/papers/20670894 | PubMed |
| 5 | 20937699 | RAD18-mediated ubiquitination of PCNA activates the Fanconi anemia DNA repair network. | J Cell Biol | 2010 | https://conductscience.org/library/papers/20937699 | PubMed |
| 6 | 21049971 | Structural basis of ubiquitin recognition by translesion synthesis DNA polymerase ι. | Biochemistry | 2010 | https://conductscience.org/library/papers/21049971 | PubMed |
| 7 | 21068376 | Suppression of Rev3, the catalytic subunit of Pol{zeta}, sensitizes drug-resistant lung tumors to chemotherapy. | Proc Natl Acad Sci U S A | 2010 | https://conductscience.org/library/papers/21068376 | PubMed |
| 8 | 21068378 | Error-prone translesion synthesis mediates acquired chemoresistance. | Proc Natl Acad Sci U S A | 2010 | https://conductscience.org/library/papers/21068378 | PubMed |
| 9 | 20929865 | Structural analysis of the conserved ubiquitin-binding motifs (UBMs) of the translesion polymerase iota in complex with ubiquitin. | J Biol Chem | 2011 | https://conductscience.org/library/papers/20929865 | PubMed |
| 10 | 21229326 | UBE2W interacts with FANCL and regulates the monoubiquitination of Fanconi anemia protein FANCD2. | Mol Cells | 2011 | https://conductscience.org/library/papers/21229326 | PubMed |
| 11 | 21709188 | Secondary somatic mutations restoring BRCA1/2 predict chemotherapy resistance in hereditary ovarian carcinomas. | J Clin Oncol | 2011 | https://conductscience.org/library/papers/21709188 | PubMed |
| 12 | 21821141 | RAD51 paralogs: roles in DNA damage signalling, recombinational repair and tumorigenesis. | Semin Cell Dev Biol | 2011 | https://conductscience.org/library/papers/21821141 | PubMed |
| 13 | 21926160 | REV1 and polymerase ζ facilitate homologous recombination repair. | Nucleic Acids Res | 2012 | https://conductscience.org/library/papers/21926160 | PubMed |
| 14 | 22266823 | Regulation of Rev1 by the Fanconi anemia core complex. | Nat Struct Mol Biol | 2012 | https://conductscience.org/library/papers/22266823 | PubMed |
| 15 | 22358330 | Y-family DNA polymerases and their role in tolerance of cellular DNA damage. | Nat Rev Mol Cell Biol | 2012 | https://conductscience.org/library/papers/22358330 | PubMed |
| 16 | 22415235 | Mutation analysis of RAD51D in non-BRCA1/2 ovarian and breast cancer families. | Br J Cancer | 2012 | https://conductscience.org/library/papers/22415235 | PubMed |
| 17 | 22467216 | Homologous recombination and its regulation. | Nucleic Acids Res | 2012 | https://conductscience.org/library/papers/22467216 | PubMed |
| 18 | 22711820 | Pol31 and Pol32 subunits of yeast DNA polymerase δ are also essential subunits of DNA polymerase ζ. | Proc Natl Acad Sci U S A | 2012 | https://conductscience.org/library/papers/22711820 | PubMed |
| 19 | 22859295 | Structural basis of Rev1-mediated assembly of a quaternary vertebrate translesion polymerase complex consisting of Rev1, heterodimeric polymerase (Pol) ζ, and Pol κ. | J Biol Chem | 2012 | https://conductscience.org/library/papers/22859295 | PubMed |
| 20 | 22904075 | En bloc transfer of polyubiquitin chains to PCNA in vitro is mediated by two different human E2-E3 pairs. | Nucleic Acids Res | 2012 | https://conductscience.org/library/papers/22904075 | PubMed |
Cited by43
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 62 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42964716 | FLASH reduces radiation-induced oral mucositis in a mouse model of Fanconi anemia. | Clin Transl Radiat Oncol | 2027 | https://conductscience.org/library/papers/42964716 | PubMed |
| 42608614 | Immunohistochemical expression of JAK2, STAT3, POLH, UBE2T, and REV7 in serous ovarian carcinoma: clinicopathological associations and co-expression patterns. | J Mol Histol | 2026 | https://conductscience.org/library/papers/42608614 | PubMed |
| 42565209 | Fungal DNA damage repair: from model to driver of virulence and AMR. | Biosci Rep | 2026 | https://conductscience.org/library/papers/42565209 | PubMed |
| 42317336 | Overcoming chemoresistance in esophageal cancer with synergistic strategies. | Front Immunol | 2026 | https://conductscience.org/library/papers/42317336 | PubMed |
| 41599340 | Mutagenic Potentials of DNA Interstrand Cross-Links Induced by 7,8-Dihydro-8-Oxoadenine. | Molecules | 2026 | https://conductscience.org/library/papers/41599340 | PubMed |
| 41510801 | HMGB1 Assists in Overcoming Cisplatin Resistance in Chemoresistant Human Ovarian Cancer Cells. | Mol Carcinog | 2026 | https://conductscience.org/library/papers/41510801 | PubMed |
| 41346410 | TSN Disrupts Fanconi Anemia Pathway Activation Through JAK/STAT1-Mediated Transcriptional Repression of FA Core Subunits in Bladder Cancer. | Dose Response | 2025 | https://conductscience.org/library/papers/41346410 | PubMed |
| 40485217 | DeSUMOylation of IGF2BP2 Promotes Neuronal Differentiation of OM-MSCs by Stabilizing SOX11 to Ameliorate Brain Injury After Intracerebral Hemorrhage. | CNS Neurosci Ther | 2025 | https://conductscience.org/library/papers/40485217 | PubMed |
| 39102671 | Analysis of translesion polymerases in colorectal cancer cells following cetuximab treatment: A network perspective. | Cancer Med | 2024 | https://conductscience.org/library/papers/39102671 | PubMed |
| 38915363 | The prognostic and predictive value of homologous recombination deficiency status in patients with advanced stage epithelial ovarian carcinoma after first-line platinum-based chemotherapy. | Front Oncol | 2024 | https://conductscience.org/library/papers/38915363 | PubMed |
| 38366290 | Interaction between lncRNAs and RNA-binding proteins (RBPs) influences DNA damage response in cancer chemoresistance. | Mol Biol Rep | 2024 | https://conductscience.org/library/papers/38366290 | PubMed |
| 38254974 | Enzymatic Processing of DNA-Protein Crosslinks. | Genes (Basel) | 2024 | https://conductscience.org/library/papers/38254974 | PubMed |
| 38063931 | Moving beyond cisplatin resistance: mechanisms, challenges, and prospects for overcoming recurrence in clinical cancer therapy. | Med Oncol | 2023 | https://conductscience.org/library/papers/38063931 | PubMed |
| 37563658 | Fance deficiency inhibits primordial germ cell proliferation associated with transcription-replication conflicts accumulate and DNA repair defects. | J Ovarian Res | 2023 | https://conductscience.org/library/papers/37563658 | PubMed |
| 37360104 | Long non-coding RNA DSCAS regulates cisplatin sensitivity in lung squamous cell carcinoma by competitively binding to miR-646-3p. | Heliyon | 2023 | https://conductscience.org/library/papers/37360104 | PubMed |
| 36480547 | RAD18 opposes transcription-associated genome instability through FANCD2 recruitment. | PLoS Genet | 2022 | https://conductscience.org/library/papers/36480547 | PubMed |
| 35785170 | Homologous Recombination Deficiency in Ovarian, Breast, Colorectal, Pancreatic, Non-Small Cell Lung and Prostate Cancers, and the Mechanisms of Resistance to PARP Inhibitors. | Front Oncol | 2022 | https://conductscience.org/library/papers/35785170 | PubMed |
| 35459258 | Genome-wide CRISPR screen identified Rad18 as a determinant of doxorubicin sensitivity in osteosarcoma. | J Exp Clin Cancer Res | 2022 | https://conductscience.org/library/papers/35459258 | PubMed |
| 35355521 | A series of xanthenes inhibiting Rad6 function and Rad6-Rad18 interaction in the PCNA ubiquitination cascade. | iScience | 2022 | https://conductscience.org/library/papers/35355521 | PubMed |
| 35205744 | Circulating Tumor Cells in Breast Cancer Patients: A Balancing Act between Stemness, EMT Features and DNA Damage Responses. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35205744 | PubMed |
Genes48
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/25795124
GET https://conductscience.org/api/papers/v1/25795124/references?page=2